Calliposis Prolongatum

Kalipoz Prolongatum: description of the medicine

Kalipoz Prolongatum (international name - potassium chloride) is a medicine produced in Poland, at the Poznan pharmaceutical plant SA Polfa Polska. It is a potassium-based remedy and is used to treat hypokalemia, or low levels of potassium in the blood.

The medicine is presented in two forms: extended-release tablets 750 mg and retard film-coated tablets 750 mg. The active substance is potassium chloride.

Indications for the use of Kalipoz Prolongatum include diseases of the cardiovascular system, nephropathies, diabetes mellitus, prolonged diarrhea, intestinal fistulas and others. The medicine is also prescribed in the treatment of antihypertensives and some diuretics, cardiac glycosides and glucocorticoids.

However, Kalipoz Prolongatum has a number of contraindications, including acute and chronic renal failure, complete heart block, treatment with potassium-sparing diuretics, hyperkalemia, metabolic disorders (acidosis, hypovolemia with hyponatremia), gastrointestinal diseases, pregnancy and breastfeeding.

In addition, Kalipoz Prolongatum can cause side effects such as dyspeptic disorders, flatulence, abdominal pain, diarrhea, ulceration, bleeding, perforation and intestinal obstruction, paresthesia and decreased blood pressure.

It is also important to consider the interaction of Kalipoz Prolongatum with other medications, such as potassium-sparing diuretics, NSAIDs and ACE inhibitors, which may increase the likelihood of developing hyperkalemia.

In case of overdose of Kalipoz Prolongatum, serious consequences can occur, such as muscle hypotonicity, paresthesia of the limbs and cardiac dysfunction, including cardiac arrest.

During treatment with Kalipoz Prolongatum, periodic monitoring of potassium concentration in the blood serum is necessary, and in patients with impaired AV conduction, the drug is prescribed with caution. In addition, a diet high in sodium chloride may increase potassium excretion from the body.

Thus, Kalipoz Prolongatum is an effective drug for the treatment of hypokalemia, but requires careful prescription and supervision by a doctor, taking into account its contraindications and side effects. Patients should monitor their diet and avoid increased sodium chloride intake, and tell their doctor about all medications they are taking to avoid unwanted interactions. If unexpected symptoms occur, you should consult a doctor for advice and recommendations.